| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -211.7% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 5.5 | n/a |
| Pr/Book | 5.2 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 10.5% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 1.70 | (3.51) | (17.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 1.16 | (6.95) | (27.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 2.40 | (10.54) | (32.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 4.57 | (8.90) | (0.28)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 5.05 | (10.62) | (0.31)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Holding(s) in Company | 17-Nov-2025 | 11:37 | RNS |
| Holding(s) in Company | 11-Nov-2025 | 09:50 | RNS |
| Enhanced IP Coverage: AT278 & Oral Peptide Program | 04-Nov-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 74.00p |
| Change Today | 1.50p |
| % Change | 2.07 % |
| 52 Week High | 86.50 |
| 52 Week Low | 38.00 |
| Volume | 16,988 |
| Shares Issued | 37.76m |
| Market Cap | £27.94m |
| Beta | 0.38 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 14:16 | 1,824 @ 76.44p |
| 12:07 | 10,000 @ 75.50p |
| 11:44 | 130 @ 76.44p |
| 10:43 | 3,891 @ 74.40p |
| 08:32 | 3 @ 70.00p |
You are here: research